These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29982508)

  • 1. Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes.
    Borgia SM; Hedskog C; Parhy B; Hyland RH; Stamm LM; Brainard DM; Subramanian MG; McHutchison JG; Mo H; Svarovskaia E; Shafran SD
    J Infect Dis; 2018 Oct; 218(11):1722-1729. PubMed ID: 29982508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses.
    Welzel TM; Bhardwaj N; Hedskog C; Chodavarapu K; Camus G; McNally J; Brainard D; Miller MD; Mo H; Svarovskaia E; Jacobson I; Zeuzem S; Agarwal K
    J Hepatol; 2017 Aug; 67(2):224-236. PubMed ID: 28343981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis.
    Esteban R; Pineda JA; Calleja JL; Casado M; Rodríguez M; Turnes J; Morano Amado LE; Morillas RM; Forns X; Pascasio Acevedo JM; Andrade RJ; Rivero A; Carrión JA; Lens S; Riveiro-Barciela M; McNabb B; Zhang G; Camus G; Stamm LM; Brainard DM; Subramanian GM; Buti M
    Gastroenterology; 2018 Oct; 155(4):1120-1127.e4. PubMed ID: 29958855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir.
    Schnell G; Krishnan P; Tripathi R; Beyer J; Reisch T; Irvin M; Dekhtyar T; Lu L; Ng TI; Xie W; Pilot-Matias T; Collins C
    PLoS One; 2018; 13(10):e0205186. PubMed ID: 30286205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Hepatitis C Virus Genotypes in Pakistan: Current Scenario and Review of Literature.
    Haqqi A; Munir R; Khalid M; Khurram M; Zaid M; Ali M; Shah ZH; Ahmed H; Afzal MS
    Viral Immunol; 2019 Nov; 32(9):402-413. PubMed ID: 31556811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofosbuvir-based treatment is safe and effective in Indian hepatitis C patients on maintenance haemodialysis: A retrospective study.
    Akhil MS; Kirushnan B; Martin M; Arumugam K; Ganesh Prasad NK; Ravichandran R
    Nephrology (Carlton); 2018 May; 23(5):446-452. PubMed ID: 28339162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a newly developed automated massively parallel sequencing assay for hepatitis C virus genotyping and detection of resistance-association variants. Comparison with a line probe assay.
    Manee N; Thongbaiphet N; Pasomsub E; Chantratita W
    J Virol Methods; 2017 Nov; 249():31-37. PubMed ID: 28851606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole genome pyrosequencing of rare hepatitis C virus genotypes enhances subtype classification and identification of naturally occurring drug resistance variants.
    Newman RM; Kuntzen T; Weiner B; Berical A; Charlebois P; Kuiken C; Murphy DG; Simmonds P; Bennett P; Lennon NJ; Birren BW; Zody MC; Allen TM; Henn MR
    J Infect Dis; 2013 Jul; 208(1):17-31. PubMed ID: 23136221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of hepatitis C viral load monitoring on direct-acting antiviral therapy.
    Sidharthan S; Kohli A; Sims Z; Nelson A; Osinusi A; Masur H; Kottilil S
    Clin Infect Dis; 2015 Jun; 60(12):1743-51. PubMed ID: 25733369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C Virus Resistance Testing in Genotype 1: The Changing Role in Clinical Utility.
    Molino S; Martin MT
    Ann Pharmacother; 2017 Sep; 51(9):811-816. PubMed ID: 28480743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Subtypes and Natural Resistance Mutations in HCV Genotype 4 Infected Saudi Arabian Patients.
    Di Stefano M; Ismail MH; Leitner T; Faleo G; Elmnan Adem SA; Elamin MOME; Eltreifi O; Alwazzeh MJ; Fiore JR; Santantonio TA
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of hepatitis C genotypes in Uttar Pradesh, India; rare genotype 4 detected.
    Prakash S; Shukla S; Ramakrishna V; Jain A
    J Med Virol; 2018 Dec; 90(12):1875-1881. PubMed ID: 30085356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 Infection.
    Martin MT; Deming P
    Pharmacotherapy; 2017 Jun; 37(6):735-747. PubMed ID: 28374965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Treatment of Untypable HCV Variants in Different Districts of Punjab, Pakistan.
    Zafar A; Imran M; Zahoor S; Shah ZH; Ali M; Afzal MS
    Viral Immunol; 2018; 31(6):426-432. PubMed ID: 29920175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sofosbuvir/Velpatasvir: The First Pangenotypic Direct-Acting Antiviral Combination for Hepatitis C.
    Chahine EB; Sucher AJ; Hemstreet BA
    Ann Pharmacother; 2017 Jan; 51(1):44-53. PubMed ID: 27609942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategy.
    Pronier C; Fontaine H; Dorival C; Carrat F; Pol S; Thibault V;
    J Viral Hepat; 2019 Nov; 26(11):1276-1283. PubMed ID: 31273896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms associated with resistance to protease inhibitors in naïve patients infected with hepatitis C virus genotype 1 in Argentina: Low prevalence of Q80K.
    Martínez AP; Culasso ACA; Pérez PS; Romano V; Campos RH; Ridruejo E; García G; Di Lello FA
    Virus Res; 2017 Aug; 240():140-146. PubMed ID: 28837817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of hepatitis C virus for determination of subtypes and detection of resistance mutations to protease inhibitors in a group of intravenous drug users co-infected with HIV.
    Silva T; Cortes Martins H; Coutinho R; Leitão E; Silva R; Pádua E
    J Med Virol; 2015 Sep; 87(9):1549-57. PubMed ID: 25940586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.
    Susser S; Dietz J; Schlevogt B; Zuckerman E; Barak M; Piazzolla V; Howe A; Hinrichsen H; Passmann S; Daniel R; Cornberg M; Mangia A; Zeuzem S; Sarrazin C
    J Hepatol; 2017 Oct; 67(4):680-686. PubMed ID: 28619439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: Identification of recombinant HCV genotype 1b-2b by viral sequencing in two patients with treatment failure, who responded to re-treatment with sofosbuvir and daclatasvir.
    Uribe-Noguez LA; Ocaña-Mondragón A; Mata-Marín JA; Cázares-Cortázar A; Ribas-Aparicio RM; Gómez-Torres ME; Gaytán-Martínez J; Martínez-Rodríguez ML
    J Infect Chemother; 2018 Nov; 24(11):928-931. PubMed ID: 29773440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.